ClassID:

95260

C07D405/12 - page 12 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3301
20160251340
2016-09-01

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

#3302
20160251339
2016-09-01

Aromatic heterocyclic compounds and their application in pharmaceuticals

#3303
20160251330
2016-09-01

Chromene derivatives as inhibitors of TCR-Nck interaction

#3304
20160251320
2016-09-01

Phenazine derivatives as anti-neoplastic agents and anti-infective agents

#3305
20160251318
2016-09-01

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#3306
20160250199
2016-09-01

Opioid receptor ligands and methods of using and making same

#3307
20160249617
2016-09-01

Tetrazolinone compound and use thereof

#3308
20160244464
2016-08-25

SUBSTITUTED BENZENE COMPOUNDS

#3309
20160244451
2016-08-25

Sulfonamide derivative and pharmaceutical use thereof

#3310
20160244410
2016-08-25

Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof

#3311
20160240790
2016-08-18

Condensed cyclic compound and organic light-emitting device including the same

#3312
20160237093
2016-08-18

Therapeutic compounds and uses thereof

#3313
20160237076
2016-08-18

Deoxycytidine kinase inhibitors

#3314
20160237070
2016-08-18

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

#3315
20160237069
2016-08-18

Inhibition of OLIG2 activity

#3316
20160237068
2016-08-18

Hydrochloride salt form for EZH2 inhibition

#3317
20160237067
2016-08-18

SUBSTITUTED PHENYLALANINE DERIVATIVES

#3318
20160237059
2016-08-18

HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE

#3319
20160237045
2016-08-18

SUBSTITUTED PHENYLALANINE DERIVATIVES

#3320
20160235761
2016-08-18

Therapeutic compounds and uses thereof

#3321
20160235706
2016-08-18

Indanyloxydihydrobenzofuranylacetic acids

#3322
20160229876
2016-08-11

Therapeutically active compositions and their methods of use

#3323
20160229838
2016-08-11

AMPK-activating heterocyclic compounds and methods for using the same

#3324
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#3325
20160229816
2016-08-11

Cyanotriazole compounds

#3326
20160229815
2016-08-11

Heterocyclic compounds for the inhibition of PASK

#3327
20160229804
2016-08-11

TrkA kinase inhibitors, compositions and methods thereof

#3328
20160229802
2016-08-11

C5AR antagonists

#3329
20160228450
2016-08-11

GLP-1 receptor modulators

#3330
20160228407
2016-08-11

1,2- bis-sulfonamide derivatives as chemokine receptor modulators

#3331
20160222016
2016-08-04

Heterocyclic compounds and uses thereof

#3332
20160222001
2016-08-04

COMT inhibiting methods and compositions

#3333
20160221995
2016-08-04

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

#3334
20160221994
2016-08-04

Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof

#3335
20160221990
2016-08-04

Cytochrome P450 inhibitors and their method of use

#3336
20160221963
2016-08-04

Pyridazinone compounds and uses thereof

#3337
20160221948
2016-08-04

NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND

#3338
20160220572
2016-08-04

Therapeutically active compounds and their methods of use

#3339
20160219879
2016-08-04

FUNGICIDAL COMPOSITIONS

#3340
20160214993
2016-07-28

GLP-1 receptor modulators

#3341
20160214985
2016-07-28

PRMT5 inhibitors and uses thereof

#3342
20160214973
2016-07-28

Store overload-induced calcium release inhibitors and methods for producing and using the same

#3343
20160214971
2016-07-28

Biaryl acyl-sulfonamide compounds as sodium channel inhibitors

#3344
20160214942
2016-07-28

Triarylamine-substituted benzo[H]quinoline-derivatives as materials for electronic devices

#3345
20160213785
2016-07-28

Lipids and compositions for the delivery of therapeutics

#3346
20160213660
2016-07-28

Phenyl derivative

#3347
20160212998
2016-07-28

Fungicidal pyrazoles

#3348
20160212997
2016-07-28

AGRICULTURAL CHEMICALS

#3349
20160207940
2016-07-21

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#3350
20160207907
2016-07-21

Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereof

#3351
20160207889
2016-07-21

Apelin receptor (APJ) agonists and uses thereof

#3352
20160207887
2016-07-21

Antidiabetic tricyclic compounds

#3353
20160207885
2016-07-21

Indol and indazol derivatives

#3354
20160207883
2016-07-21

Aromatic compound and use thereof

#3355
20160206596
2016-07-21

Anti-depression compounds

#3356
20160206594
2016-07-21

Pro-neurogenic compounds

#3357
20160205935
2016-07-21

Tetrazolinone compound and use of same

#3358
20160205933
2016-07-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests

#3359
20160200732
2016-07-14

Carbazole-containing sulfonamides as cryptochrome modulators

#3360
20160200712
2016-07-14

PROCESSES FOR PRODUCING CYCLOALKYLCARBOXAMIDO-PYRIDINE BENZOIC ACIDS

#3361
20160200695
2016-07-14

Methods and compositions for selective and targeted cancer therapy

#3362
20160200686
2016-07-14

Benzimidazolyl-methyl urea derivatives as ALX receptor agonists

#3363
20160200685
2016-07-14

Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases

#3364
20160200684
2016-07-14

Pharmaceutical Compositions for the Treatment of CFTR-Mediated Disorders

#3365
20160200681
2016-07-14

Tetrahydrocyclopentapyrrole derivatives and a method for preparing the same

#3366
20160197277
2016-07-07

Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment

#3367
20160194316
2016-07-07

Substituted benzene compounds

#3368
20160194311
2016-07-07

Substituted nicotinamide derivatives as kinase inhibitors

#3369
20160194307
2016-07-07

Compounds useful as immunomodulators

#3370
20160194284
2016-07-07

Allosteric modulators of the cannabinoid 1 receptor

#3371
20160193218
2016-07-07

Quinazolinones as bromodomain inhibitors

#3372
20160193184
2016-07-07

Method for induction of a heat shock protein, anti-stress or regulation of an autonomic nerve

#3373
20160190477
2016-06-30

Organic electroluminescence composition, material for organic electroluminescence element, solution of material for organic electroluminescence element, and organic electroluminescence element

#3374
20160185818
2016-06-30

Bidentate-binding modulators of LRRK2 and JNK kinases

#3375
20160185783
2016-06-30

ACC inhibitors and uses thereof

#3376
20160185747
2016-06-30

N-cycloalkyl-N-[(fusedphenyl)methylene]-(thio)carboxamide derivatives

#3377
20160185736
2016-06-30

Triazine derivative and pharmaceutical composition comprising the same

#3378
20160185728
2016-06-30

Cyanoquinoline derivatives

#3379
20160185727
2016-06-30

Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers

#3380
20160185726
2016-06-30

Anthelmintic compounds and compositions and method of using thereof

#3381
20160184318
2016-06-30

Autotaxin inhibitors

#3382
20160184308
2016-06-30

Aminopyrimidine derivatives for use as modulators of kinase activity

#3383
20160181525
2016-06-23

Compound, organic electroluminescent element material, organic electroluminescent element, and electronic device

#3384
20160176900
2016-06-23

SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS AS KINASE INHIBITOR COMPOUNDS

#3385
20160176854
2016-06-23

Imidazolecarboxamides and their use as FAAH inhibitors

#3386
20160176836
2016-06-23

Bifunctional compounds

#3387
20160176826
2016-06-23

Inhibitors of ACK1/TNK2 tyrosine kinase

#3388
20160176825
2016-06-23

Kinase inhibitors for the treatment of disease

#3389
20160176820
2016-06-23

Aurora kinase inhibitors

#3390
20160176817
2016-06-23

Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#3391
20160176801
2016-06-23

Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment

#3392
20160168165
2016-06-16

Myc modulators and uses thereof

#3393
20160168146
2016-06-16

Compounds and methods for kinase modulation, and indications therefor

#3394
20160168144
2016-06-16

COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1

#3395
20160168132
2016-06-16

DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

#3396
20160168119
2016-06-16

AUTOTAXIN INHIBITORS

#3397
20160168113
2016-06-16

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#3398
20160168096
2016-06-16

Biaryl derivatives as GPR120 agonists

#3399
20160168090
2016-06-16

Indole derivatives and their use in neurodegenerative diseases

#3400
20160166540
2016-06-16

MODULATORS FOR ATP-BINDING CASSETTE TRANSPORTERS

#3401
20160159820
2016-06-09

Fused tricyclic amide compounds as multiple kinase inhibitors

#3402
20160159815
2016-06-09

Fused piperidine amides as modulators of ion channels

#3403
20160159784
2016-06-09

N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof

#3404
20160159752
2016-06-09

Piperazine derivatives as HIV protease inhibitors

#3405
20160158230
2016-06-09

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

#3406
20160158209
2016-06-09

Compounds for treatment of alzheimer's disease

#3407
20160152604
2016-06-02

Substituted 6,5-fused bicyclic heteroaryl compounds

#3408
20160152577
2016-06-02

2,4-Diaminoquinazolines for Spinal Muscular Atrophy

#3409
20160152569
2016-06-02

Pyridyl inhibitors of hedgehog signalling

#3410
20160150782
2016-06-02

USE OF SELECTED PYRIDONE CARBOXAMIDES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS

#3411
20160149141
2016-05-26

Amine-based compounds and organic light-emitting devices comprising the same

#3412
20160145247
2016-05-26

Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof

#3413
20160145237
2016-05-26

Protein tyrosine kinase modulators and methods of use

#3414
20160145220
2016-05-26

Nitrogen-containing saturated heterocyclic compound

#3415
20160145199
2016-05-26

3-aryl propiolonitrile compounds for thiol labeling

#3416
20160143870
2016-05-26

IDO inhibitors

#3417
20160141508
2016-05-19

Materials for electronic devices

#3418
20160139158
2016-05-19

Fluorogenic pH sensitive dyes and their method of use

#3419
20160139136
2016-05-19

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#3420
20160137659
2016-05-19

Chromane and chromene derivatives and their use as CRAC modulators

#3421
20160137633
2016-05-19

PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES

#3422
20160137632
2016-05-19

BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE

#3423
20160137631
2016-05-19

PRMT5 inhibitors and uses thereof

#3424
20160137609
2016-05-19

Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof

#3425
20160135464
2016-05-19

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#3426
20160130266
2016-05-12

α-oxoacyl amino-caprolactam

#3427
20160130262
2016-05-12

N-substituted azetidine derivatives

#3428
20160129128
2016-05-12

Antibody drug conjugates

#3429
20160129032
2016-05-12

Substituted quinazolines as receptor-type kinase inhibitors

#3430
20160126468
2016-05-05

Indenoindole derivative and organic electroluminescent element

#3431
20160122334
2016-05-05

INHIBITORS OF C-FMS KINASE

#3432
20160122329
2016-05-05

Crystalline forms of afatinib di-maleate

#3433
20160115147
2016-04-28

PRO-DRUG COMPOUNDS

#3434
20160115134
2016-04-28

Bromodomain inhibitors

#3435
20160115131
2016-04-28

Histone demethylase inhibitors

#3436
20160115128
2016-04-28

Aromatic compounds with GPR40 agonistic activity

#3437
20160115125
2016-04-28

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#3438
20160115119
2016-04-28

α-Substituted glycinamide derivative

#3439
20160108025
2016-04-21

POLYCYCLIC HERG ACTIVATORS

#3440
20160108016
2016-04-21

Novel Cannabinergic Compounds and Uses Thereof

#3441
20160107997
2016-04-21

CXCR7 receptor modulators

#3442
20160107996
2016-04-21

Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof

#3443
20160106742
2016-04-21

Pyruvate kinase activators for use in therapy

#3444
20160102091
2016-04-14

Heterocyclic modulators of lipid synthesis

#3445
20160102078
2016-04-14

Tubulin polymerization inhibitor and method for synthesizing same

#3446
20160102077
2016-04-14

Indole-3-carboxamides as kinase inhibitors

#3447
20160102059
2016-04-14

Kinase inhibitors

#3448
20160102054
2016-04-14

Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)

#3449
20160096828
2016-04-07

Indole-1-carboxamides as kinase inhibitors

#3450
20160096827
2016-04-07

Tank-binding kinase inhibitor compounds

#3451
20160096805
2016-04-07

Kinase inhibitor

#3452
20160095856
2016-04-07

Substituted indazole derivatives active as kinase inhibitors

#3453
20160095828
2016-04-07

Compositions and methods for treating metabolic disorders

#3454
20160090393
2016-03-31

Neprilysin inhibitors

#3455
20160090383
2016-03-31

ANTIBACTERIAL PHTHALIDE DERIVATIVES

#3456
20160090378
2016-03-31

Estrogen receptor modulators and uses thereof

#3457
20160090377
2016-03-31

Azetidine estrogen receptor modulators and uses thereof

#3458
20160090364
2016-03-31

PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS

#3459
20160083373
2016-03-24

Method for preparing Afatinib and intermediate thereof

#3460
20160083372
2016-03-24

Neprilysin inhibitors

#3461
20160083362
2016-03-24

Tricyclic sulphonamide compounds and methods of making and using same

#3462
20160083354
2016-03-24

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#3463
20160083349
2016-03-24

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#3464
20160083342
2016-03-24

Sulfur derivatives as chemokine receptor modulators

#3465
20160082008
2016-03-24

ERK inhibitors and uses thereof

#3466
20160081982
2016-03-24

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#3467
20160081339
2016-03-24

Tetrazolinone compound and use of same

#3468
20160079546
2016-03-17

Condensed cyclic compound and organic light-emitting device including the same

#3469
20160075677
2016-03-17

Synthesis of resorcylic acid lactones useful as therapeutic agents

#3470
20160075663
2016-03-17

Benzoimidazol-1,2-yl amides as Kv7 channel activators

#3471
20160075662
2016-03-17

Indazolyl- and indolyl-benzamide derivatives

#3472
20160075656
2016-03-17

QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

#3473
20160074381
2016-03-17

Modulators of cellular adhesion

#3474
20160074361
2016-03-17

Pro-neurogenic compounds

#3475
20160068541
2016-03-10

Analgesic compounds and methods of use

#3476
20160068489
2016-03-10

Amidopyridinol derivative or pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same as active component

#3477
20160068487
2016-03-10

Compounds as diacylglycerol acyltransferase inhibitors

#3478
20160068482
2016-03-10

Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors

#3479
20160067240
2016-03-10

Allosteric inhibitors of thymidylate synthase

#3480
20160064669
2016-03-03

Aromatic amine derivatives and organic electroluminescent elements using same

#3481
20160060262
2016-03-03

Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses Thereof

#3482
20160060260
2016-03-03

BROMODOMAIN INHIBITORS FOR TREATING DISEASE

#3483
20160060231
2016-03-03

SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

#3484
20160060222
2016-03-03

AMINO-QUINOLINES AS KINASE INHIBITORS

#3485
20160060218
2016-03-03

Strigolactam derivatives as plant growth regulating compounds

#3486
20160058895
2016-03-03

RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS

#3487
20160058745
2016-03-03

Casein kinase 1delta (CK1delta) inhibitors

#3488
20160052928
2016-02-25

Intermediate of Ticagrelor and preparation method therefor, and preparation method for Ticagrelor

#3489
20160052926
2016-02-25

NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF

#3490
20160052916
2016-02-25

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

#3491
20160052910
2016-02-25

Compositions and methods for cancer detection and treatment

#3492
20160052890
2016-02-25

Compounds useful as antibiotic tolerance inhibitors

#3493
20160052862
2016-02-25

Nitroso compounds as nitroxyl donors and methods of use thereof

#3494
20160051548
2016-02-25

Piperazine-substituted benzothiophenes for treatment of mental disorders

#3495
20160051512
2016-02-25

N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#3496
20160050925
2016-02-25

Fungicidal amides

#3497
20160046642
2016-02-18

Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

#3498
20160046638
2016-02-18

Certain protein kinase inhibitors

#3499
20160046616
2016-02-18

NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

#3500
20160046612
2016-02-18

Heterocyclic derivative and pharmaceutical drug

#3501
20160046602
2016-02-18

Inhibitors of c-fms kinase

#3502
20160046592
2016-02-18

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES

#3503
20160046583
2016-02-18

Isoquinoline derivatives

#3504
20160046581
2016-02-18

Factor XIa inhibitors

#3505
20160046579
2016-02-18

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#3506
20160046574
2016-02-18

Serotonin receptor modulators

#3507
20160045477
2016-02-18

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3508
20160039834
2016-02-11

CARM1 inhibitors and uses thereof

#3509
20160039800
2016-02-11

DOSAGE UNITS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D] [1,3] DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

#3510
20160039781
2016-02-11

Analogues of epicatechin and related polyphenols

#3511
20160039771
2016-02-11

Dihydroxy aromatic heterocyclic compound

#3512
20160039769
2016-02-11

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#3513
20160039768
2016-02-11

Pyrazole indanyl carboxamides

#3514
20160039755
2016-02-11

Oxindole compounds, solvent-free synthesis and use thereof

#3515
20160038504
2016-02-11

Biaryl amide compounds as kinase inhibitors

#3516
20160031907
2016-02-04

Substituted Benzene Compounds

#3517
20160031880
2016-02-04

NAMPT and ROCK inhibitors

#3518
20160031864
2016-02-04

Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers

#3519
20160031862
2016-02-04

CYCLOALKYL-SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS

#3520
20160031861
2016-02-04

Substituted oxetanes and their use as inhibitors of cathepsin C

#3521
20160031830
2016-02-04

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

#3522
20160031825
2016-02-04

Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

#3523
20160031820
2016-02-04

Substituted hydroxamic acids and uses thereof

#3524
20160031813
2016-02-04

Nampt Inhibitors

#3525
20160030428
2016-02-04

Pyrimidinedione compounds

#3526
20160028015
2016-01-28

Amine-based compound and organic light-emitting diode including the same

#3527
20160024072
2016-01-28

Heterocyclic ring and carbocyclic derivative

#3528
20160024058
2016-01-28

Process for preparing benzofuran-2-carboxamide derivatives

#3529
20160024038
2016-01-28

Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release

#3530
20160024027
2016-01-28

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#3531
20160024022
2016-01-28

Pyrimidines as sodium channel blockers

#3532
20160024021
2016-01-28

Pyrimidine and pyridine compounds and their usage

#3533
20160024020
2016-01-28

Intermediates to prepare herbicidal pyrimidone derivatives

#3534
20160024017
2016-01-28

Arginine methyltransferase inhibitors and uses thereof

#3535
20160024016
2016-01-28

Arginine methyltransferase inhibitors and uses thereof

#3536
20160024008
2016-01-28

Process for preparing benzofuran-2-carboxamide derivatives

#3537
20160023991
2016-01-28

PPAR agonists

#3538
20160023987
2016-01-28

Benzocycloalkenes as antifungal agents

#3539
20160022693
2016-01-28

Aryl- or heteroaryl-substituted benzene compounds

#3540
20160022670
2016-01-28

Benzamides

#3541
20160022626
2016-01-28

Spliceostatin analogs and methods for their preparation

#3542
20160021883
2016-01-28

Molecules having certain pesticidal utilities, intermediates, compositions, and processes, related thereto

#3543
20160016941
2016-01-21

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#3544
20160016940
2016-01-21

Indole and indazole compounds that activate AMPK

#3545
20160016933
2016-01-21

Isoquinolines as potassium ion channel inhibitors

#3546
20160016929
2016-01-21

PRO-DRUG COMPOUNDS

#3547
20160016928
2016-01-21

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#3548
20160016927
2016-01-21

Dihydrobenzofuran derivatives as insecticidal compounds

#3549
20160016918
2016-01-21

Neprilysin inhibitors

#3550
20160016910
2016-01-21

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#3551
20160009703
2016-01-14

Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof

#3552
20160009691
2016-01-14

SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS

#3553
20160009677
2016-01-14

Tricyclic compound and use thereof

#3554
20160009666
2016-01-14

Antiviral compounds

#3555
20160009662
2016-01-14

Substituted pyrazines as GPR40 agonists

#3556
20160009661
2016-01-14

2,4-pyrimidinediamine compounds and their uses

#3557
20160009660
2016-01-14

2,4-pyrimidinediamine compounds and their uses

#3558
20160009659
2016-01-14

Pyrimidine carboxamides as sodium channel blockers

#3559
20160008494
2016-01-14

Tau imaging probe

#3560
20160008326
2016-01-14

Bicyclic compound, production and use thereof

#3561
20160007602
2016-01-14

Macrocyclic picolinamides as fungicides

#3562
20160007601
2016-01-14

Macrocyclic picolinamides as fungicides

#3563
20160002254
2016-01-07

Therapeutic compounds and uses thereof

#3564
20160002176
2016-01-07

ERK inhibitors and uses thereof

#3565
20160002175
2016-01-07

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#3566
20160002148
2016-01-07

Neprilysin inhibitors

#3567
20160000781
2016-01-07

Phthalazinone derivatives

#3568
20160000760
2016-01-07

Antiviral compounds

#3569
20150380659
2015-12-31

Compound, organic light emitting element comprising same, and display device comprising organic light emitting element

#3570
20150376212
2015-12-31

Flap modulators

#3571
20150376169
2015-12-31

Histone demethylase inhibitors

#3572
20150376146
2015-12-31

SODIUM CHANNEL BLOCKERS

#3573
20150376130
2015-12-31

N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists

#3574
20150374690
2015-12-31

Heteroaryl compounds and uses thereof

#3575
20150368295
2015-12-24

Method for producing pyrazoles, novel pyrazoles and applications thereof

#3576
20150368270
2015-12-24

FLAP modulators

#3577
20150368230
2015-12-24

RADIOLABELED QUINAZOLINE DERIVATIVES

#3578
20150368205
2015-12-24

Poly (ADP-ribose) polymerase inhibitor

#3579
20150361090
2015-12-17

Labeled chemically reactive and biologically active comjugates, and methods and compositions thereof

#3580
20150361075
2015-12-17

Compounds that modulate intracellular calcium

#3581
20150361073
2015-12-17

Processes for preparing antiviral compounds

#3582
20150361072
2015-12-17

Pyridine derivatives as soft rock inhibitors

#3583
20150361061
2015-12-17

Methods of treating an overweight or obese subject

#3584
20150361055
2015-12-17

Sulfoximine substituted quinazolines for pharmaceutical compositions

#3585
20150361042
2015-12-17

PRMT5 inhibitors and uses thereof

#3586
20150357575
2015-12-10

Amine-based compound and organic light-emitting device including the same

#3587
20150353601
2015-12-10

Compounds for enzyme inhibition

#3588
20150353505
2015-12-10

Phthalazinones and isoquinolinones as rock inhibitors

#3589
20150353499
2015-12-10

Antiproliferative benzo [B] azepin-2-ones

#3590
20150353494
2015-12-10

Aryl- or heteroaryl-substituted benzene compounds

#3591
20150353492
2015-12-10

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

#3592
20150352219
2015-12-10

Conjugate compounds

#3593
20150352119
2015-12-10

Substituted benzene compounds

#3594
20150352106
2015-12-10

Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine

#3595
20150344467
2015-12-03

5- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS

#3596
20150344466
2015-12-03

Method for controlling arthropod pest

#3597
20150344457
2015-12-03

METHODS OF INHIBITING PRMT5

#3598
20150344452
2015-12-03

Procaspase activating compounds

#3599
20150344444
2015-12-03

BET-PROTEIN-INHIBITING DIHYDROXYQUINOXALINONES

#3600
20150344443
2015-12-03

Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof